Back to mobile site

More on OCR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.0 Score)
- Holders
- Dividends (0.9% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

OCR Cash Flow Statement

Click line-items for a historical chart and %
Net income 111.36M
Loss from discontinued operations 0
Depreciation expense 29.62M
Amortization expense 36.12M
Debt redemption costs, net
Tender premium
Accounts receivable and unbilled receivables, net of provision for doubtful accounts
Inventories 42.67M
Other current and noncurrent assets 121.38M
Accounts payable 74.09M
Accrued employee compensation 9.43M
Deferred revenue
Current and noncurrent liabilities 54.29M
Net cash flows from operating activities of continuing operations 430.35M
Net cash flows from operating activities of discontinued operations 0
Net cash flows from operating activities 430.35M
Acquisition of businesses, net of cash received -54.8M
Divestiture of business, net 0
Capital expenditures -27.66M
Other 0
Net cash flows used in investing activities of continuing operations -82.47M
Net cash flows used in investing activities of discontinued operations 0
Net cash flows used in investing activities -82.47M
Net payments on revolving credit facilities and Term A loan -10M
Proceeds from long term borrowings and obligations
Payments on long-term borrowings and obligations -6M
Fees paid for financing arrangements -2.24M
Increase (decrease) in cash overdraft balance 1.29M
Proceeds (payments) for stock awards and exercise of stock options, net of stock tendered in payment
Payments for Omnicare common stock repurchase (Note 2) -125M
Dividends paid -42.36M
Other 5.56M
Net cash flows used in financing activities of continuing operations
Net cash flows used in financing activities -186.97M
Net increase (decrease) in cash and cash equivalents 160.91M
Less increase in cash and cash equivalents of discontinued operations 0
Increase (decrease) in cash and cash equivalents of continuing operations
Cash and cash equivalents at beginning of period 153.8M
Cash and cash equivalents at end of period 314.71M